<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38272997</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>29</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Jan</Month><Day>25</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Transcranial direct current stimulation (tDCS) in the treatment of neuropsychiatric symptoms of long COVID.</ArticleTitle><Pagination><StartPage>2193</StartPage><MedlinePgn>2193</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">2193</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-024-52763-4</ELocationID><Abstract><AbstractText>The study aimed to assess the efficacy of transcranial direct current stimulation (tDCS) in the treatment of neuropsychiatric (NP) symptoms of the post-acute sequelae of SARS-CoV-2 infection (PASC), known as the long COVID. A double-blind, randomized, sham-controlled study compared the efficacy and safety of prefrontal cortex active tDCS to sham-tDCS in treating NP-PASC. Patients diagnosed with NP-PASC, with a Fatigue Impact Scale (FIS) score&#x2009;&#x2265;&#x2009;40, were eligible for the study. Twenty tDCS sessions were administered within four weeks, with continuous, end-of-treatment, and follow-up measurements. The primary outcome was a change in the FIS at the end-of-treatment, analyzed in the intention-to-treat population. Data from 33 patients assigned to active (n&#x2009;=&#x2009;16) or sham-tDCS (n&#x2009;=&#x2009;17) were analyzed. After the treatment, a decrease in the FIS score was more pronounced in the sham than in the active group, yet the intergroup difference was insignificant (11.7 [95% CI -11.1 to 34.5], p&#x2009;=&#x2009;0.6). Furthermore, no significant intergroup differences were observed regarding anxiety, depression, quality of life, and cognitive performance. The small cohort sample, differences in baseline FIS scores between groups (non-stratified randomization), or chosen stimulation parameters may have influenced our findings. However, it might also be possible that the expected mechanism of action of tDCS is insufficient to treat these conditions.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Kl&#xed;rov&#xe1;</LastName><ForeName>Monika</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>National Institute of Mental Health, Topolov&#xe1; 748, 250 67, Klecany, Czech Republic. klirovamonika@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Third Faculty of Medicine, Charles University, Prague, Czech Republic. klirovamonika@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Adamov&#xe1;</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>National Institute of Mental Health, Topolov&#xe1; 748, 250 67, Klecany, Czech Republic.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Third Faculty of Medicine, Charles University, Prague, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bia&#x10d;kov&#xe1;</LastName><ForeName>Nina</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>National Institute of Mental Health, Topolov&#xe1; 748, 250 67, Klecany, Czech Republic.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Third Faculty of Medicine, Charles University, Prague, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laskov</LastName><ForeName>Olga</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>National Institute of Mental Health, Topolov&#xe1; 748, 250 67, Klecany, Czech Republic.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Third Faculty of Medicine, Charles University, Prague, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Renkov&#xe1;</LastName><ForeName>Veronika</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>National Institute of Mental Health, Topolov&#xe1; 748, 250 67, Klecany, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stuchl&#xed;kov&#xe1;</LastName><ForeName>Zuzana</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Third Faculty of Medicine, Charles University, Prague, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Odnohov&#xe1;</LastName><ForeName>Karol&#xed;na</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>National Institute of Mental Health, Topolov&#xe1; 748, 250 67, Klecany, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nov&#xe1;k</LastName><ForeName>Tom&#xe1;&#x161;</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>National Institute of Mental Health, Topolov&#xe1; 748, 250 67, Klecany, Czech Republic.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Third Faculty of Medicine, Charles University, Prague, Czech Republic.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>NU22-D-133</GrantID><Agency>Ministerstvo Zdravotnictv&#xed; Cesk&#xe9; Republiky (Ministry of Health of the Czech Republic)</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065908" MajorTopicYN="Y">Transcranial Direct Current Stimulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017397" MajorTopicYN="N">Prefrontal Cortex</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>ZS: Hospital &#x10c;esk&#xe9; Bud&#x11b;jovice, a.s., &#x10c;esk&#xe9; Bud&#x11b;jovice, Czechia; KO: Second Faculty of Medicine, Charles University, Prague, the Czech Republic. Other authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>10</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>1</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>29</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>26</Day><Hour>0</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>25</Day><Hour>23</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38272997</ArticleId><ArticleId IdType="pmc">PMC10810850</ArticleId><ArticleId IdType="doi">10.1038/s41598-024-52763-4</ArticleId><ArticleId IdType="pii">10.1038/s41598-024-52763-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Carf&#xec;, A., Bernabei, R., Landi, F., &amp; for the Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent symptoms in patients after acute COVID-19. JAMA324, 603&#x2013;605 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, et al. Post-acute COVID-19 syndrome. Nat. Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Premraj L, et al. Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis. J. Neurol. Sci. 2022;434:120162. doi: 10.1016/j.jns.2022.120162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2022.120162</ArticleId><ArticleId IdType="pmc">PMC8798975</ArticleId><ArticleId IdType="pubmed">35121209</ArticleId></ArticleIdList></Reference><Reference><Citation>Rolin S, Chakales A, Verduzco-Gutierrez M. Rehabilitation strategies for cognitive and neuropsychiatric manifestations of COVID-19. Curr. Phys. Med. Rehabil. Rep. 2022;10:182&#x2013;187. doi: 10.1007/s40141-022-00352-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40141-022-00352-9</ArticleId><ArticleId IdType="pmc">PMC9107067</ArticleId><ArticleId IdType="pubmed">35602927</ArticleId></ArticleIdList></Reference><Reference><Citation>Mudd PA, et al. Targeted immunosuppression distinguishes COVID-19 from influenza in moderate and severe disease. Preprint. 2020 doi: 10.1101/2020.05.28.20115667.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.05.28.20115667</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahamed J, Laurence J. Long COVID endotheliopathy: Hypothesized mechanisms and potential therapeutic approaches. J. Clin. Invest. 2022;132:33. doi: 10.1172/JCI161167.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI161167</ArticleId><ArticleId IdType="pmc">PMC9337829</ArticleId><ArticleId IdType="pubmed">35912863</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrera JE, et al. Multidisciplinary collaborative consensus guidance statement on the assessment and treatment of fatigue in postacute sequelae of SARS-CoV-2 infection (PASC) patients. PM R. 2021;13:1027&#x2013;1043. doi: 10.1002/pmrj.12684.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pmrj.12684</ArticleId><ArticleId IdType="pmc">PMC8441628</ArticleId><ArticleId IdType="pubmed">34346558</ArticleId></ArticleIdList></Reference><Reference><Citation>Eilam-Stock T, et al. Telehealth transcranial direct current stimulation for recovery from post-acute sequelae of SARS-CoV-2 (PASC) Brain Stimul. Basic Transl. Clin. Res. Neuromodul. 2021;14:1520&#x2013;1522.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8514329</ArticleId><ArticleId IdType="pubmed">34655835</ArticleId></ArticleIdList></Reference><Reference><Citation>Lefaucheur J-P, et al. The treatment of fatigue by non-invasive brain stimulation. Neurophysiol. Clin./Clin. Neurophysiol. 2017;47:173&#x2013;184. doi: 10.1016/j.neucli.2017.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neucli.2017.03.003</ArticleId><ArticleId IdType="pubmed">28410876</ArticleId></ArticleIdList></Reference><Reference><Citation>Leffa DT, et al. Transcranial direct current stimulation improves long-term memory deficits in an animal model of attention-deficit/hyperactivity disorder and modulates oxidative and inflammatory parameters. Brain Stimul. 2018;11:743&#x2013;751. doi: 10.1016/j.brs.2018.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brs.2018.04.001</ArticleId><ArticleId IdType="pubmed">29656905</ArticleId></ArticleIdList></Reference><Reference><Citation>Fl&#xf6;el A. tDCS-enhanced motor and cognitive function in neurological diseases. NeuroImage. 2014;85:934&#x2013;947. doi: 10.1016/j.neuroimage.2013.05.098.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2013.05.098</ArticleId><ArticleId IdType="pubmed">23727025</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyde J, et al. Efficacy of neurostimulation across mental disorders: Systematic review and meta-analysis of 208 randomized controlled trials. Mol. Psychiatry. 2022;27:2709&#x2013;2719. doi: 10.1038/s41380-022-01524-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-022-01524-8</ArticleId><ArticleId IdType="pmc">PMC8973679</ArticleId><ArticleId IdType="pubmed">35365806</ArticleId></ArticleIdList></Reference><Reference><Citation>Lefaucheur J-P, et al. Evidence-based guidelines on the therapeutic use of transcranial direct current stimulation (tDCS) Clin. Neurophysiol. 2017;128:56&#x2013;92. doi: 10.1016/j.clinph.2016.10.087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2016.10.087</ArticleId><ArticleId IdType="pubmed">27866120</ArticleId></ArticleIdList></Reference><Reference><Citation>Brunoni AR, et al. Transcranial direct current stimulation for acute major depressive episodes: Meta-analysis of individual patient data. Br. J. Psychiatry. 2016;208:522&#x2013;531. doi: 10.1192/bjp.bp.115.164715.</Citation><ArticleIdList><ArticleId IdType="doi">10.1192/bjp.bp.115.164715</ArticleId><ArticleId IdType="pmc">PMC4887722</ArticleId><ArticleId IdType="pubmed">27056623</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrucci R, et al. Transcranial direct current stimulation (tDCS) for fatigue in multiple sclerosis. NeuroRehabilitation. 2014;34:121&#x2013;127. doi: 10.3233/NRE-131019.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/NRE-131019</ArticleId><ArticleId IdType="pubmed">24284464</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaudhuri A, Behan PO. Fatigue in neurological disorders. Lancet. 2004;363:978&#x2013;988. doi: 10.1016/S0140-6736(04)15794-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(04)15794-2</ArticleId><ArticleId IdType="pubmed">15043967</ArticleId></ArticleIdList></Reference><Reference><Citation>Okano AH, et al. Brain stimulation modulates the autonomic nervous system, rating of perceived exertion and performance during maximal exercise. Br. J. Sports Med. 2015;49:1213&#x2013;1218. doi: 10.1136/bjsports-2012-091658.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bjsports-2012-091658</ArticleId><ArticleId IdType="pubmed">23446641</ArticleId></ArticleIdList></Reference><Reference><Citation>Suchting R, Colpo GD, Rocha NP, Ahn H. The effect of transcranial direct current stimulation on inflammation in older adults with knee osteoarthritis: A Bayesian residual change analysis. Biol. Res. Nurs. 2020;22:57&#x2013;63. doi: 10.1177/1099800419869845.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1099800419869845</ArticleId><ArticleId IdType="pmc">PMC7068751</ArticleId><ArticleId IdType="pubmed">31416344</ArticleId></ArticleIdList></Reference><Reference><Citation>Baptista AF, et al. Neuromodulation and inflammatory reflex: Perspectives on the use of non-invasive neuromodulation in the management of disorders related to COVID-19. Preprint. 2020 doi: 10.2139/ssrn.3601048.</Citation><ArticleIdList><ArticleId IdType="doi">10.2139/ssrn.3601048</ArticleId></ArticleIdList></Reference><Reference><Citation>Iseger TA, van Bueren NER, Kenemans JL, Gevirtz R, Arns M. A frontal-vagal network theory for major depressive disorder: Implications for optimizing neuromodulation techniques. Brain Stimul. 2020;13:1&#x2013;9. doi: 10.1016/j.brs.2019.10.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brs.2019.10.006</ArticleId><ArticleId IdType="pubmed">31668983</ArticleId></ArticleIdList></Reference><Reference><Citation>Dantzer R. Neuroimmune interactions: From the brain to the immune system and vice versa. Physiol. Rev. 2018;98:477&#x2013;504. doi: 10.1152/physrev.00039.2016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00039.2016</ArticleId><ArticleId IdType="pmc">PMC5866360</ArticleId><ArticleId IdType="pubmed">29351513</ArticleId></ArticleIdList></Reference><Reference><Citation>Simpson R, Robinson L. Rehabilitation after critical illness in people with COVID-19 infection. Am. J. Phys. Med. Rehabil. 2020;99:470. doi: 10.1097/PHM.0000000000001443.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PHM.0000000000001443</ArticleId><ArticleId IdType="pmc">PMC7253039</ArticleId><ArticleId IdType="pubmed">32282359</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf3;mez L, Vidal B, Cabrera Y, Hern&#xe1;ndez L, Rond&#xf3;n Y. Successful treatment of post-COVID symptoms with transcranial direct current stimulation. Prim. Care Companion CNS Disord. 2021;23:38522. doi: 10.4088/PCC.21cr03059.</Citation><ArticleIdList><ArticleId IdType="doi">10.4088/PCC.21cr03059</ArticleId><ArticleId IdType="pubmed">34861746</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliver-Mas S, et al. Transcranial direct current stimulation for post-COVID fatigue: A randomized, double-blind, controlled pilot study. Brain Commun. 2023;5:117. doi: 10.1093/braincomms/fcad117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcad117</ArticleId><ArticleId IdType="pmc">PMC10116605</ArticleId><ArticleId IdType="pubmed">37091591</ArticleId></ArticleIdList></Reference><Reference><Citation>Santana K, et al. Non-invasive brain stimulation for fatigue in post-acute sequelae of SARS-CoV-2 (PASC) Brain Stimul. 2023;16:100&#x2013;107. doi: 10.1016/j.brs.2023.01.1672.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brs.2023.01.1672</ArticleId><ArticleId IdType="pmc">PMC9867562</ArticleId><ArticleId IdType="pubmed">36693536</ArticleId></ArticleIdList></Reference><Reference><Citation>Workman C, Boles-Ponto L, Kamholz J, Bryant A, Rudroff T. Transcranial direct current stimulation and post-COVID-19-fatigue. Brain Stimul. Basic Transl. Clin. Res. Neuromodul. 2021;14:1672&#x2013;1673.</Citation></Reference><Reference><Citation>Rudroff T, Fietsam A, Deters J, Bryant A, Kamholz J. tDCS improves perceptions of fatigue in patients with post-COVID-19-symptoms that are less than 6 months post-infection. Brain Stimul. Basic Transl. Clin. Res. Neuromodul. 2023;16:249.</Citation></Reference><Reference><Citation>Brunoni AR, et al. Efficacy of transcranial direct current stimulation and cognitive training for the neurocognitive symptoms of long covid-19. Brain Stimul. Basic Transl. Clin. Res. Neuromodul. 2023;16:192.</Citation></Reference><Reference><Citation>Vestito L, et al. Impact of tDCS on persistent COVID-19 olfactory dysfunction: A double-blind sham-controlled study. J. Neurol. Neurosurg. Psychiatry. 2023;94:87&#x2013;88. doi: 10.1136/jnnp-2022-329162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2022-329162</ArticleId><ArticleId IdType="pubmed">35606106</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrade SM, et al. Efficacy and safety of HD-tDCS and respiratory rehabilitation for critically ill patients with COVID-19. The HD-RECOVERY randomized clinical trial. Brain Stimul. 2022;15:780&#x2013;788. doi: 10.1016/j.brs.2022.05.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brs.2022.05.006</ArticleId><ArticleId IdType="pmc">PMC9093082</ArticleId><ArticleId IdType="pubmed">35568312</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto TP, et al. Prefrontal tDCS modulates autonomic responses in COVID-19 inpatients. Brain Stimul. 2023;16:657&#x2013;666. doi: 10.1016/j.brs.2023.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brs.2023.03.001</ArticleId><ArticleId IdType="pmc">PMC10027235</ArticleId><ArticleId IdType="pubmed">36940750</ArticleId></ArticleIdList></Reference><Reference><Citation>Shinjo SK, Brunoni AR, Okano AH, Tanaka C, Baptista AF. Transcranial direct current stimulation relieves the severe anxiety of a patient with COVID-19. Brain Stimul. 2020;13:1352&#x2013;1353. doi: 10.1016/j.brs.2020.07.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brs.2020.07.004</ArticleId><ArticleId IdType="pmc">PMC7366123</ArticleId><ArticleId IdType="pubmed">32682750</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavendish BA, et al. Combination of transcranial direct current stimulation with online cognitive training improves symptoms of post-acute sequelae of COVID-19: A case series. Brain Stimul. Basic Transl. Clin. Res. Neuromodul. 2022;15:1375&#x2013;1377.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9528061</ArticleId><ArticleId IdType="pubmed">36202328</ArticleId></ArticleIdList></Reference><Reference><Citation>Esmaeili L, Ramezanpoor A. The effectiveness of transcranial direct current stimulation of the brain (tDCS) on depressive syndrome in improved individuals from Covid-19. Neuropsychology. 2022;8:49&#x2013;58.</Citation></Reference><Reference><Citation>Rosen AC, et al. TDCS in a patient with dreadlocks: Improvements in COVID-19 related verbal fluency dysfunction. Brain Stimul. Basic Transl. Clin. Res. Neuromodul. 2022;15:254&#x2013;256.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8741329</ArticleId><ArticleId IdType="pubmed">35007779</ArticleId></ArticleIdList></Reference><Reference><Citation>Wysoki&#x144;ski A, Szczepocka E, Szczakowska A. Improved cognitive performance, increased theta, alpha, beta and decreased delta powers after cognitive rehabilitation augmented with tDCS in a patient with post-COVID-19 cognitive impairment (brain-fog) Psychiatry Res. Case Rep. 2023;2:100164.</Citation></Reference><Reference><Citation>Antal A, et al. Low intensity transcranial electric stimulation: Safety, ethical, legal regulatory and application guidelines. Clin. Neurophysiol. 2017;128:1774&#x2013;1809. doi: 10.1016/j.clinph.2017.06.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2017.06.001</ArticleId><ArticleId IdType="pmc">PMC5985830</ArticleId><ArticleId IdType="pubmed">28709880</ArticleId></ArticleIdList></Reference><Reference><Citation>Kan RLD, et al. Effects of non-invasive brain stimulation in multiple sclerosis: Systematic review and meta-analysis. Ther. Adv. Chronic Dis. 2022;13:20406223211069198. doi: 10.1177/20406223211069198.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20406223211069198</ArticleId><ArticleId IdType="pmc">PMC8814979</ArticleId><ArticleId IdType="pubmed">35126965</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez-Garcia P, et al. From cell to symptoms: The role of SARS-CoV-2 cytopathic effects in the pathogenesis of COVID-19 and long COVID. Int. J. Mol. Sci. 2023;24:8290. doi: 10.3390/ijms24098290.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24098290</ArticleId><ArticleId IdType="pmc">PMC10179575</ArticleId><ArticleId IdType="pubmed">37175995</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal AD, et al. SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC) Nat. Immunol. 2023 doi: 10.1038/s41590-023-01601-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-023-01601-2</ArticleId><ArticleId IdType="pubmed">37667052</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukaetova-Ladinska EB, Kronenberg G. Psychological and neuropsychiatric implications of COVID-19. Eur. Arch. Psychiatry Clin. Neurosci. 2021;271:235&#x2013;248. doi: 10.1007/s00406-020-01210-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00406-020-01210-2</ArticleId><ArticleId IdType="pmc">PMC7680256</ArticleId><ArticleId IdType="pubmed">33221936</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner S, et al. Long COVID: Pathophysiological factors and abnormalities of coagulation. Trends Endocrinol. Metab. 2023;34:321&#x2013;344. doi: 10.1016/j.tem.2023.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tem.2023.03.002</ArticleId><ArticleId IdType="pmc">PMC10113134</ArticleId><ArticleId IdType="pubmed">37080828</ArticleId></ArticleIdList></Reference><Reference><Citation>Burkhardt G, et al. 572. Transcranial direct current stimulation as add-on to selective serotonin reuptake inhibitors in adults with major depressive disorder: Results: from the depression DC trial. Biol. Psychiatry. 2023;93:S325&#x2013;S326. doi: 10.1016/j.biopsych.2023.02.812.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopsych.2023.02.812</ArticleId></ArticleIdList></Reference><Reference><Citation>De Doncker W, Ondobaka S, Kuppuswamy A. Effect of transcranial direct current stimulation on post-stroke fatigue. J. Neurol. 2021;268:2831&#x2013;2842. doi: 10.1007/s00415-021-10442-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10442-8</ArticleId><ArticleId IdType="pmc">PMC8289762</ArticleId><ArticleId IdType="pubmed">33598767</ArticleId></ArticleIdList></Reference><Reference><Citation>Batsikadze G, Moliadze V, Paulus W, Kuo M-F, Nitsche MA. Partially non-linear stimulation intensity-dependent effects of direct current stimulation on motor cortex excitability in humans. J. Physiol. 2013;591:1987&#x2013;2000. doi: 10.1113/jphysiol.2012.249730.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.2012.249730</ArticleId><ArticleId IdType="pmc">PMC3624864</ArticleId><ArticleId IdType="pubmed">23339180</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassanzahraee M, Nitsche MA, Zoghi M, Jaberzadeh S. Determination of anodal tDCS intensity threshold for reversal of corticospinal excitability: An investigation for induction of counter-regulatory mechanisms. Sci. Rep. 2020;10:16108. doi: 10.1038/s41598-020-72909-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-72909-4</ArticleId><ArticleId IdType="pmc">PMC7527486</ArticleId><ArticleId IdType="pubmed">32999375</ArticleId></ArticleIdList></Reference><Reference><Citation>Forogh B, et al. Repeated sessions of transcranial direct current stimulation evaluation on fatigue and daytime sleepiness in Parkinson&#x2019;s disease. Neurol. Sci. 2017;38:249&#x2013;254. doi: 10.1007/s10072-016-2748-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-016-2748-x</ArticleId><ArticleId IdType="pubmed">27796604</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong X-L, et al. A randomized controlled trial to explore the efficacy and safety of transcranial direct current stimulation on patients with post-stroke fatigue. Medicine. 2021;100:45. doi: 10.1097/MD.0000000000027504.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000027504</ArticleId><ArticleId IdType="pmc">PMC8519229</ArticleId><ArticleId IdType="pubmed">34731132</ArticleId></ArticleIdList></Reference><Reference><Citation>Chalah MA, et al. Effects of left DLPFC versus right PPC tDCS on multiple sclerosis fatigue. J. Neurol. Sci. 2017;372:131&#x2013;137. doi: 10.1016/j.jns.2016.11.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2016.11.015</ArticleId><ArticleId IdType="pubmed">28017199</ArticleId></ArticleIdList></Reference><Reference><Citation>Tecchio F, et al. Multiple sclerosis fatigue relief by bilateral somatosensory cortex neuromodulation. J. Neurol. 2014;261:1552&#x2013;1558. doi: 10.1007/s00415-014-7377-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-014-7377-9</ArticleId><ArticleId IdType="pubmed">24854634</ArticleId></ArticleIdList></Reference><Reference><Citation>Tecchio F, et al. Brain plasticity effects of neuromodulation against multiple sclerosis fatigue. Front. Neurol. 2015;6:42. doi: 10.3389/fneur.2015.00141.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2015.00141</ArticleId><ArticleId IdType="pmc">PMC4490242</ArticleId><ArticleId IdType="pubmed">26191036</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancelli A, et al. Personalized, bilateral whole-body somatosensory cortex stimulation to relieve fatigue in multiple sclerosis. Mult. Scler. 2018;24:1366&#x2013;1374. doi: 10.1177/1352458517720528.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1352458517720528</ArticleId><ArticleId IdType="pubmed">28756744</ArticleId></ArticleIdList></Reference><Reference><Citation>Jamil A, et al. Systematic evaluation of the impact of stimulation intensity on neuroplastic after-effects induced by transcranial direct current stimulation. J. Physiol. 2017;595:1273&#x2013;1288. doi: 10.1113/JP272738.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/JP272738</ArticleId><ArticleId IdType="pmc">PMC5309387</ArticleId><ArticleId IdType="pubmed">27723104</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobbs B, et al. Generalizing remotely supervised transcranial direct current stimulation (tDCS): Feasibility and benefit in Parkinson&#x2019;s disease. J. NeuroEng. Rehabil. 2018;15:114. doi: 10.1186/s12984-018-0457-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12984-018-0457-9</ArticleId><ArticleId IdType="pmc">PMC6284269</ArticleId><ArticleId IdType="pubmed">30522497</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>